Versatile by design.

Physical Therapy

From complexity to clarity.

SmartVertigo™ helps you capture, replay, and document the eye movements observed during standardized positional testing — supporting your assessment and your notes.

• Visualize horizontal, vertical, and torsional nystagmus in high resolution.
• Replay at variable speed to confirm subtle findings.
• Compare recordings visit-over-visit to document progress.
• Show patients their own eye movements to support education and adherence.

Audiology / ENT

Extend your vestibular workflow — without another booth.

A portable capture tool that complements your existing VNG and vHIT workflows — ideal for satellite locations, bedside testing, or high-throughput screening days.

• Run nystagmus capture in any exam room or remote clinic site.
• PDF documentation that files alongside your existing records.
• A quick, focused oculomotor screen to help triage referrals.

Emergency Departments

Objective documentation at the bedside.

Acute dizziness is one of the most over-imaged presentations in the ED. SmartVertigo™ provides verified nystagmus capture at the bedside — a durable, contemporaneous data element for the chart.

• Bedside eye-movement recording in a few minutes.
• Objective, reproducible documentation to support the disposition and the record.
• A contemporaneous medicolegal record of what was observed.

Neurology

Document and replay nystagmus patterns.

An objective platform for capturing, replaying, and longitudinally tracking nystagmus — a high-fidelity eye-movement record for every encounter.

• Capture and replay direction-changing, gaze-evoked, and torsional findings at controlled speed.
• Objective serial recordings for episodic vertigo, vestibular migraine, and post-concussion follow-up.
• A durable record to complement clinical judgement — never a substitute for it.

Context on ED imaging: approximately 35% of patients presenting to the emergency department with dizziness receive brain imaging (Adams et al., JAMA Otolaryngol Head Neck Surg, 2022), and 93.1% of such scans have been reported as unremarkable (Masood et al., Cureus, 2024). SmartVertigo™ is intended to support documentation and clinician judgement, not to replace clinical evaluation or imaging decisions.